Insights

Geographic Expansion Opportunities Julphar's recent investments in Saudi Arabia, including establishing a new biologics and sterile manufacturing facility, highlight a strategic focus on expanding into the rapidly growing healthcare markets in the Middle East and Africa, offering potential sales opportunities for suppliers and partners aligned with these regions.

Product Portfolio Growth With an extensive portfolio that includes generic medicines, branded generics, and OTC products, Julphar presents opportunities for collaboration in expanding product lines, supply chain efficiencies, and innovative formulations to meet increasing regional demand.

Innovation and R&D Focus Julphar's investment in advanced biologics and sterile manufacturing facilities indicates a push toward high-value, innovative pharmaceutical products, opening doors for high-tech suppliers, R&D collaborations, and life sciences technology partners.

Regional Market Penetration Having a presence in over 40 countries and a network across the Middle East and Africa places Julphar in a prime position to leverage distribution channels and gain access to untapped markets or expand existing product reach through strategic partnerships.

Financial Growth & Stability Consistent top-line growth and profit acceleration, alongside significant investments in manufacturing assets, suggest a financially healthy organization open to large-scale procurement deals, joint ventures, and long-term supply agreements to support its expansion plans.

Julphar Tech Stack

Julphar uses 8 technology products and services including Docker, HTML, C++, and more. Explore Julphar's tech stack below.

  • Docker
    Containerization
  • HTML
    Programming Languages
  • C++
    Programming Languages
  • HSTS
    Security
  • Bootstrap
    UI Frameworks
  • YouTube
    Video Players
  • SAP NetWeaver
    Web And Application Servers
  • Twitter
    Widgets

Media & News

Julphar's Email Address Formats

Julphar uses at least 1 format(s):
Julphar Email FormatsExamplePercentage
First.Last@julphar.netJohn.Doe@julphar.net
85%
FLast@julphar.netJDoe@julphar.net
11%
Last@julphar.netDoe@julphar.net
2%
FirstLa@julphar.netJohnDo@julphar.net
2%

Frequently Asked Questions

What is Julphar's phone number?

Minus sign iconPlus sign icon
You can contact Julphar's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Julphar's official website and social media links?

Minus sign iconPlus sign icon
Julphar's official website is julphar.net and has social profiles on LinkedIn.

How much revenue does Julphar generate?

Minus sign iconPlus sign icon
As of December 2025, Julphar's annual revenue is estimated to be $6M.

What is Julphar's SIC code NAICS code?

Minus sign iconPlus sign icon
Julphar's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Julphar have currently?

Minus sign iconPlus sign icon
As of December 2025, Julphar has approximately 3K employees across 5 continents, including AsiaAfricaNorth America. Key team members include Chief Executive Officer: B. Z.Chief Executive Officer: E. M.Chief Executive Officer: E. F.. Explore Julphar's employee directory with LeadIQ.

What industry does Julphar belong to?

Minus sign iconPlus sign icon
Julphar operates in the Pharmaceutical Manufacturing industry.

What technology does Julphar use?

Minus sign iconPlus sign icon
Julphar's tech stack includes DockerHTMLC++HSTSBootstrapYouTubeSAP NetWeaverTwitter.

What is Julphar's email format?

Minus sign iconPlus sign icon
Julphar's email format typically follows the pattern of First.Last@julphar.net. Find more Julphar email formats with LeadIQ.

When was Julphar founded?

Minus sign iconPlus sign icon
Julphar was founded in 1980.

Julphar

Pharmaceutical ManufacturingRa’s al Khaymah, United Arab Emirates1001-5000 Employees

The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. 

Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ over 3000 people, and we market our products in more than 40 countries. We have 10 internationally accredited facilities that produce more one million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines.

Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1980
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Julphar's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Julphar's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.